Is the Internet to Blame for Unsafe Drug Use? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Is the Internet to Blame for Unsafe Drug Use?
FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.


Pharmaceutical Technology
Volume 34, Issue 2, pp. 14


Angie Drakulich
Just before the New Year began, FDA warned the public that criminals were claiming to be agency officials and coercing individuals over the phone to pay fines as high as $250,000 for the illegal purchase of pharmaceuticals. These FDA impersonators somehow obtained records of individuals who had purchased pharmaceuticals online or through telepharmacies and told the individuals that their purchases were illegal. The impersonators asked that a fine be wired, most often to a location in the Dominican Republic.

The international scam is taking advantage of individuals who seek to buy their medication online rather than from a doctor or pharmacy. Often, online drug products are less expensive and provide more convenience and privacy.

The purchase of pharmaceuticals on the Internet is legal with a valid prescription. But in a consumer-safety guide on the subject, FDA warns that not all online pharmacies are US state-licensed, protect personal information, or provide accurate medication for the patient's condition. There's also the possibility of counterfeit or expired drugs being sold.

Fraudulent federal officials capitalizing on the growing business are now giving patients another reason to be paranoid about opting for online pharmacies. The fact is, according to FDA's website, even if a crime was committed, agents and other law enforcement officials are not authorized to impose or collect criminal fines. Only a court can take such action. FDA is working with other government agencies to pursue these criminals, who have also posed as special agents of the FBI, DEA, and more. The scam isn't entirely new. In late 2008, FDA warned of fraudulent special agents that were enticing individuals to buy discounted drugs over the phone—of course, the products were never delivered.

Although the Internet has provided the world with uncountable benefits, it seems to have opened a can of worms for the pharmaceutical industry—and for patients.

Angie Drakulich is managing editor of Pharmaceutical Technology.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here